The parcel carrier Veho is launching a novel service that allows online retailers to slash shipping costs by opting for flexible delivery windows, challenging the industry's rigid speed paradigm and offering a new tool in the fight against rising last-mile expenses.
Palantir Technologies' shares surged nearly 7% following a blockbuster earnings report, fueled by a 66% jump in U.S. government revenue. The data analytics firm, a key Pentagon and intelligence community contractor, is riding a wave of increased defense spending, though its high valuation and controversial ICE surveillance work draw mixed reactions from investors and analysts.
While Health Savings Accounts offer a powerful triple tax advantage, a common withdrawal habit is undermining their long-term potential for millions of savers.
Tyler Technologies moves to acquire digital court-recording specialist For The Record in a cash deal valued at $212.5 million, aiming to integrate advanced AI-powered transcription and SaaS solutions into its public sector suite.
Amid broader market skepticism about AI adoption and sustainability, Palantir Technologies delivered a quarter of explosive growth, shattering expectations and forecasting continued momentum through 2026.
Pfizer reported a quarterly loss driven by significant asset impairments and declining COVID-19 product sales, sending shares lower. The pharmaceutical giant reaffirmed its 2026 financial targets but signaled no share buybacks as it prioritizes debt reduction and a costly R&D pipeline aimed at replacing lost patent revenues.
Despite a Complete Response Letter for its epinephrine film Anaphylm, Aquestive Therapeutics receives a vote of confidence from Leerink Partners. The firm highlights a 'silver lining,' noting the FDA's requests appear addressable without major new studies, setting a defined, though delayed, route to potential U.S. approval.
Armed with artificial intelligence, a new wave of solo entrepreneurs is competing in the consumer packaged goods arena, using the technology for everything from market research to strategic planning—tasks once reserved for large corporate teams.
Merck & Co. reported solid Q4 2025 results, driven by oncology and new launches, while detailing a robust pipeline it believes can deliver over $70 billion in commercial potential by the mid-2030s, aiming to ensure growth past Keytruda's patent expiration.
The health insurance giant is rolling out an 'Agent Assist' tool to its 20,000+ call center workers, aiming to boost efficiency, accuracy, and consistency in member service while targeting over $100 million in operational savings.
As CarMax shares languish nearly 50% below last year's levels, investment firm BML Capital Management has taken a significant new position, signaling a vote of confidence in the used-car retailer's long-term strategy and financial resilience.
JPMorgan Chase expands its Iowa footprint with a new Ames branch, anchoring its arrival with a seven-figure philanthropic package aimed at fueling small business innovation and resilience across the state.
The Direxion Daily S&P 500 Bull 3X Shares (SPXL) and ProShares Ultra QQQ (QLD) have delivered outsized gains by magnifying index moves. As market momentum shows signs of slowing, investors weigh the sustainability of these high-octane strategies against rising risks.
Nicolas Lecocq traded predawn bakery shifts for a computer screen, teaching himself to code. His frustration with complex WordPress themes led him to build OceanWP—a free tool that amassed over 500,000 users and generated millions, though not without costly lessons.
Medtronic moves to acquire CathWorks and its AI-powered coronary artery disease diagnostic system, aiming to solidify its position in the catheterization lab and streamline treatment decisions.
Vera Therapeutics elevates Matt Skelton to Chief Commercial Officer, signaling a strategic shift towards commercialization as its lead drug candidate, atacicept for IgA nephropathy, undergoes FDA Priority Review with a PDUFA date set for July 2026.
Cameco's shares have skyrocketed over 138% in the past year, riding a wave of renewed global interest in nuclear energy. But as the stock trades near record highs, a deep dive into valuation metrics raises critical questions about whether the current price still offers value or signals a bubble.
As the automotive retail industry gathers in Las Vegas, a year of market volatility has cemented a 'back-to-basics' mindset, with profitability through fixed operations and used vehicles taking center stage.
McDonald's re-enters the top 10 of Entrepreneur's Franchise 500, climbing from 22nd place, driven by a strategic return to value-focused offerings like the $5 meal deal and the Snack Wrap.
As markets recalibrate amid shifting Fed expectations, income-focused strategies gain prominence. We analyze two REITs with standout 8%+ yields and 'Strong Buy' ratings from Wall Street, examining their resilience and income-generating potential.
